We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Blog

Food Poisoning Bacteria’s Sugar Coating Could Be It’s Undoing
Blog

To learn how Campylobacter hides from the body’s immune system, why some people are more susceptible than others, and the potential role that carbohydrate-based diagnostics could play in the fight against the bacterium, we spoke to Professor Rob Field, Co-founder of Iceni Diagnostics.

Read More

Exploring the Fourth Dimension of Proteome Analysis
Blog

Recent developments in MS technology have enabled a fourth dimension of analysis: ion mobility separation. The term "4D proteomics" has been created to describe analysis that incorporates all four dimensions. We interviewed two researchers at the forefront of the proteomics field to learn more about how 4D proteomics approaches are enhancing their research.


Read More

Clinical Proteomics and Computational Biochemistry With Professor Jürgen Cox
Blog

Technology Networks recently spoke with Professor Jürgen Cox to learn more about the computational software tools his laboratory are developing, and how 4D proteomics workflows enhance research in clinical proteomics.

Read More

Talking Clinical Proteomics With Dr Roman Fischer
Blog

Technology Networks spoke with Dr Roman Fischer to learn more about the challenges researchers face in the field of clinical proteomics, and how 4D proteomics workflows are enhancing his laboratory's work.

Read More

Digital Technology Enhancing Lateral Flow Diagnostics
Blog

Digitization is a trend threading many disciplines, and lateral flow is no exception. Here, we share insights from Dave Taylor, co-founder and chief operating officer of Bond Digital Health, a UK-based life sciences company that develops app and cloud technology solutions for lateral flow diagnostics.

Read More

10 Things to Note About Manufacturing Viral Vectors
Blog

10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.

Read More

Harnessing the Power of Proteins To Unlock Cell and Gene Therapies
Blog

We recently spoke with Paul Wotton, Ph.D., CEO at Obsidian Therapeutics, to gain his insights on the genetically engineered cell-therapy research area, and to learn how Obsidian Therapeutics' cytoDRiVE platform can increases the specificity and safety of such therapies.

Read More

Developing Novel Therapies for the Treatment of Respiratory Diseases
Blog

We recently had the pleasure of speaking with Martin Gosling, Enterprise Therapeutics’ CSO and Professor of Molecular Pharmacology at the University of Sussex. Martin highlights the respiratory diseases Enterprise Therapeutics primarily focus on and the new disease modifying therapies they have in development.

Read More

Enabling Accurate One-step DNA Assembly
Blog

Long sequences of DNA are a key requirement for researchers to be able to develop novel synthetic biomolecules. However, assembling long sequences can prove problematic and slow down the process of gene assembly. GenBrick™ utilizes a novel proprietary technology to enable accurate one-step DNA assembly. We spoke with Cedric Wu, Ph.D., GenScript Sr. Director of R&D to learn more about the capabilities of GenBrick™.

Read More

Using Artificial Intelligence to Identify Bloodborne Bacteria
Blog

Fluid Imaging Technologies and the University of Colorado Boulder have recently entered an exclusive research agreement to determine whether the University’s artificial intelligence software can identify bloodborne bacteria. We spoke with Kent Peterson, CEO, Fluid Imaging Technologies, to learn more about the collaboration, the technologies involved, and how they could impact patients.

Read More